This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Resolution of Hyperglycemia on Risperidone Discontinuation: A Case Report

Ashok Mallya, Pooja Chawla, Susan K. Boyer, and Lori DeRosear

Published: May 12, 2002

Article Abstract

Letter to the Editor

Sir: Because atypical antipsychotic agents are being increasingly prescribed as first-line agents in the treatment of psychotic symptoms, concern about treatment-emergent weight gain and hyperglycemia has increased. A MEDLINE search from 1995 to 2001 using the keywords hyperglycemia, risperidone, diabetes, olanzapine, quetiapine, and clozapine revealed several reports of hyperglycemia associated with clozapine and olanzapine, but only 2 reports of risperidone-associated hyperglycemia. Diabetes mellitus was an infrequently observed (0.1%-1%) event during premarketing evaluation of risperidone.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 63

Quick Links: